Report Highlights

This report covers the impact of AI on targeted alpha therapies for cancer treatment market. It highlights how AI is reshaping the key industry verticals and how niche market players are investing in AI to gain control.

Report Includes

• An analysis of the AI impact on global market for targeted alpha therapies for cancer treatment
• Insights of the key Use Cases for AI implementation in developing personalized alpha radioligand therapies (ARTs)
• Understanding of AI adoption trends in RESS market across the four major global regions
• Impact analysis of AI on various stages of development of targeted alpha therapies for cancer, including drug discovery and development, clinical trials and optimization, and supply chain and manufacturing
• Impact of AI on various stages of the value chain for manufacturing and supply chain of radiopharmaceutical drugs
• Insights of the market spending and forecasting analysis of niche players

Report Scope

As reported by the World Health Organization (WHO), an estimated 9.7 million people died from cancer, and 20 million new cases were reported in 2022. It is reported that the global cancer cases will rise by 77% by the end of 2050, to a total of 35 million. Although traditional treatments such as radiotherapy, chemotherapy and surgery have made improvements, they frequently harm healthy tissues inadvertently. Radiopharmaceutical therapy (RPT) is a new approach that uses radioactive materials to target cancer cells while preserving healthy organs. AI can transform the process of developing new radiopharmaceuticals, enhance pharmacodynamics and streamline the drug discovery process. AI speeds up the process by using machine learning (ML) and deep learning (DL) approaches to identify targets faster, design molecules more effectively and develop better radiolabeling procedures. Radiopharmaceuticals will revolutionize healthcare, improve the quality of outcomes and open new avenues for precision medicine with the aid of AI.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.